Cargando…

Epidemic progression and vaccination in a heterogeneous population. Application to the Covid-19 epidemic

The paper is devoted to a compartmental epidemiological model of infection progression in a heterogeneous population which consists of two groups with high disease transmission (HT) and low disease transmission (LT) potentials. Final size and duration of epidemic, the total and current maximal numbe...

Descripción completa

Detalles Bibliográficos
Autores principales: Volpert, Vitaly, Banerjee, Malay, Sharma, Swarnali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157369/
http://dx.doi.org/10.1016/j.ecocom.2021.100940
_version_ 1783699668089176064
author Volpert, Vitaly
Banerjee, Malay
Sharma, Swarnali
author_facet Volpert, Vitaly
Banerjee, Malay
Sharma, Swarnali
author_sort Volpert, Vitaly
collection PubMed
description The paper is devoted to a compartmental epidemiological model of infection progression in a heterogeneous population which consists of two groups with high disease transmission (HT) and low disease transmission (LT) potentials. Final size and duration of epidemic, the total and current maximal number of infected individuals are estimated depending on the structure of the population. It is shown that with the same basic reproduction number [Formula: see text] in the beginning of epidemic, its further progression depends on the ratio between the two groups. Therefore, fitting the data in the beginning of epidemic and the determination of [Formula: see text] are not sufficient to predict its long time behaviour. Available data on the Covid-19 epidemic allows the estimation of the proportion of the HT and LT groups. Estimated structure of the population is used for the investigation of the influence of vaccination on further epidemic development. The result of vaccination strongly depends on the proportion of vaccinated individuals between the two groups. Vaccination of the HT group acts to stop the epidemic and essentially decreases the total number of infected individuals at the end of epidemic and the current maximal number of infected individuals while vaccination of the LT group only acts to protect vaccinated individuals from further infection.
format Online
Article
Text
id pubmed-8157369
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-81573692021-05-28 Epidemic progression and vaccination in a heterogeneous population. Application to the Covid-19 epidemic Volpert, Vitaly Banerjee, Malay Sharma, Swarnali Ecological Complexity Article The paper is devoted to a compartmental epidemiological model of infection progression in a heterogeneous population which consists of two groups with high disease transmission (HT) and low disease transmission (LT) potentials. Final size and duration of epidemic, the total and current maximal number of infected individuals are estimated depending on the structure of the population. It is shown that with the same basic reproduction number [Formula: see text] in the beginning of epidemic, its further progression depends on the ratio between the two groups. Therefore, fitting the data in the beginning of epidemic and the determination of [Formula: see text] are not sufficient to predict its long time behaviour. Available data on the Covid-19 epidemic allows the estimation of the proportion of the HT and LT groups. Estimated structure of the population is used for the investigation of the influence of vaccination on further epidemic development. The result of vaccination strongly depends on the proportion of vaccinated individuals between the two groups. Vaccination of the HT group acts to stop the epidemic and essentially decreases the total number of infected individuals at the end of epidemic and the current maximal number of infected individuals while vaccination of the LT group only acts to protect vaccinated individuals from further infection. Elsevier B.V. 2021-09 2021-05-27 /pmc/articles/PMC8157369/ http://dx.doi.org/10.1016/j.ecocom.2021.100940 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Volpert, Vitaly
Banerjee, Malay
Sharma, Swarnali
Epidemic progression and vaccination in a heterogeneous population. Application to the Covid-19 epidemic
title Epidemic progression and vaccination in a heterogeneous population. Application to the Covid-19 epidemic
title_full Epidemic progression and vaccination in a heterogeneous population. Application to the Covid-19 epidemic
title_fullStr Epidemic progression and vaccination in a heterogeneous population. Application to the Covid-19 epidemic
title_full_unstemmed Epidemic progression and vaccination in a heterogeneous population. Application to the Covid-19 epidemic
title_short Epidemic progression and vaccination in a heterogeneous population. Application to the Covid-19 epidemic
title_sort epidemic progression and vaccination in a heterogeneous population. application to the covid-19 epidemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157369/
http://dx.doi.org/10.1016/j.ecocom.2021.100940
work_keys_str_mv AT volpertvitaly epidemicprogressionandvaccinationinaheterogeneouspopulationapplicationtothecovid19epidemic
AT banerjeemalay epidemicprogressionandvaccinationinaheterogeneouspopulationapplicationtothecovid19epidemic
AT sharmaswarnali epidemicprogressionandvaccinationinaheterogeneouspopulationapplicationtothecovid19epidemic